Health Effects of a Nordic Diet Rich in Plant-based Foods and Fish

Sponsor
Finnish Institute for Health and Welfare (Other)
Overall Status
Completed
CT.gov ID
NCT01412346
Collaborator
Academy of Finland (Other), University of Oslo (Other)
111
1
2
44
2.5

Study Details

Study Description

Brief Summary

The purpose of this study is to investigate the effects of a Nordic diet rich in plant-based foods and fish on indicators of cardiovascular disease risk at two different levels of salt intake.

The study is a 20-wk randomized controlled crossover trial. The subjects follow a salt-restricted diet during the study. The study begins with a 4-wk run-in phase for all subjects. After that the subjects are randomly allocated to one of two groups. Group 1 consumes a healthy Nordic low-salt diet enriched with plant-based foods and fish for 16 weeks. Group 2 consumes a low-salt diet for 16 weeks. During the 16 weeks, both groups receive salt and placebo capsules in a double-blind, crossover fashion (8+8 weeks).

Condition or Disease Intervention/Treatment Phase
  • Other: Effects of a Nordic diet rich in plant-based foods and fish
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
111 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Health Effects of a Nordic Diet Rich in Plant-based Foods and Fish
Study Start Date :
Jan 1, 2011
Actual Primary Completion Date :
Jun 1, 2012
Actual Study Completion Date :
Sep 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Plant-based food and fish with salt restr.

The subjects consume plant based foods (fruits, berries, vegetables, whole grain) and fish in addition to a salt-restricted diet. Intake of salt is normal to high for 8 weeks and low for 8 weeks (subjects receive salt and placebo capsules in a crossover design).

Other: Effects of a Nordic diet rich in plant-based foods and fish
The intervention lasts for 20 weeks and it includes dietary counseling concerning salt restriction. Key foods are provided to the subjects.

Placebo Comparator: Diet with salt restriction

The subjects follow a salt-restricted diet. Intake of salt is normal to high for 8 weeks and low for 8 weeks (subjects receive salt and placebo capsules in a crossover design).

Other: Effects of a Nordic diet rich in plant-based foods and fish
The intervention lasts for 20 weeks and it includes dietary counseling concerning salt restriction. Key foods are provided to the subjects.

Outcome Measures

Primary Outcome Measures

  1. Change from baseline in systolic and diastolic blood pressure after treatments [12 and 20 weeks]

Secondary Outcome Measures

  1. Change from baseline in PFA-100 measurements after treatments [12 and 20 weeks]

  2. Change from baseline in biomarkers of cardiovascular disease risk after treatments [12 and 20 weeks]

  3. Change from baseline in nutritional biomarkers after treatments [12 and 20 weeks]

  4. Change from baseline in blood cell gene expression after treatments [12 and 20 weeks]

Eligibility Criteria

Criteria

Ages Eligible for Study:
45 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • prehypertension or hypertension (systolic blood pressure 130-159 mmHg or diastolic blood pressure 85-99 mmHg)
Exclusion Criteria:
  • smoking

  • regular use of medications

  • intestinal disorders

  • symptomatic cardiovascular disease

  • obesity (BMI>35 kg/m2)

  • vegetarianism

  • high intake of alcohol

  • allergy to fish

  • pregnancy

Contacts and Locations

Locations

Site City State Country Postal Code
1 National Institute for Health and Welfare Helsinki Finland FI-00271

Sponsors and Collaborators

  • Finnish Institute for Health and Welfare
  • Academy of Finland
  • University of Oslo

Investigators

  • Study Director: Iris Erlund, Dr., Finnish Institute for Health and Welfare
  • Study Director: Antti Jula, Dr., Finnish Institute for Health and Welfare

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Iris Erlund, PhD., senior researcher, Finnish Institute for Health and Welfare
ClinicalTrials.gov Identifier:
NCT01412346
Other Study ID Numbers:
  • NPHIKTL_022011
First Posted:
Aug 9, 2011
Last Update Posted:
Oct 15, 2014
Last Verified:
Oct 1, 2014
Keywords provided by Iris Erlund, PhD., senior researcher, Finnish Institute for Health and Welfare
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 15, 2014